DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)

DAE HWA Pharmaceutical Revenue

DAE HWA Pharmaceutical had revenue of 37.03B KRW in the quarter ending March 31, 2026, with 0.99% growth. This brings the company's revenue in the last twelve months to 143.42B, down -5.26% year-over-year. In the year 2025, DAE HWA Pharmaceutical had annual revenue of 143.06B, down -4.25%.

• Revenue (ttm): 143.42B
• Revenue Growth: -5.26%
• P/S Ratio: 1.32
• Revenue / Employee: 465.66M
• Employees: 308
• Market Cap: 189.53B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	143.06B	-6.35B	-4.25%
Dec 31, 2024	149.41B	8.05B	5.69%
Dec 31, 2023	141.36B	9.45B	7.16%
Dec 31, 2022	131.91B	14.75B	12.59%
Dec 31, 2021	117.16B	7.81B	7.15%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 9, 2026

Data Sources Report a data error